🇮🇳·13h agoIndustry
natco and lupin receive approval from u s fda for eribulin mesylate injection
Publisher
N
Natco Pharma
India
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- Natco Pharma
- Region
- India
- Scope
- Industry
- Published
- July 27, 2026
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on natcopharma.co.in
Leave the platform to read the original full article on the publisher site.
Source: Natco Pharma
Scope: Industry
Related coverage
More related coverage
Bambusa Therapeutics/3h ago
Bambusa Therapeutics Reports Potentially Transformative Preliminary Proof-of-Concept Results for BBT001 in Atopic Dermatitis, Reinforcing Its Best-in-Disease Potential
Otsuka Pharmaceutical/11h ago
Otsuka Launches POCARI SWEAT ION WATER Powder Stick Packet to Make 500mlEasy Water and Ion Replenishment for Day-to-Day Situations: Ideal for Use with Reusable Bottles
Otsuka Holdings RSS/13h ago
Otsuka Receives FDA Approval for First-in-Class SIMTRIYO (centanafadine) for the Treatment of Attention-Deficit Hyperactivity Disorder (ADHD) in Adults and Pediatric Patients Aged 6 Years and Older
Natco Pharma/13h ago